280 related articles for article (PubMed ID: 35910387)
1. Epac: A Promising Therapeutic Target for Vascular Diseases: A Review.
Pan Y; Liu J; Ren J; Luo Y; Sun X
Front Pharmacol; 2022; 13():929152. PubMed ID: 35910387
[TBL] [Abstract][Full Text] [Related]
2. Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2 distribution and function in cardiomyocytes.
Pereira L; Rehmann H; Lao DH; Erickson JR; Bossuyt J; Chen J; Bers DM
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3991-6. PubMed ID: 25829540
[TBL] [Abstract][Full Text] [Related]
3. The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1).
Courilleau D; Bouyssou P; Fischmeister R; Lezoualc'h F; Blondeau JP
Biochem Biophys Res Commun; 2013 Oct; 440(3):443-8. PubMed ID: 24099776
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP Sensor EPAC Proteins and Their Role in Cardiovascular Function and Disease.
Lezoualc'h F; Fazal L; Laudette M; Conte C
Circ Res; 2016 Mar; 118(5):881-97. PubMed ID: 26941424
[TBL] [Abstract][Full Text] [Related]
5. PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells.
Roscioni SS; Kistemaker LE; Menzen MH; Elzinga CR; Gosens R; Halayko AJ; Meurs H; Schmidt M
Respir Res; 2009 Sep; 10(1):88. PubMed ID: 19788733
[TBL] [Abstract][Full Text] [Related]
6. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).
Banales JM; Masyuk TV; Gradilone SA; Masyuk AI; Medina JF; LaRusso NF
Hepatology; 2009 Jan; 49(1):160-74. PubMed ID: 19065671
[TBL] [Abstract][Full Text] [Related]
7. Cell physiology of cAMP sensor Epac.
Holz GG; Kang G; Harbeck M; Roe MW; Chepurny OG
J Physiol; 2006 Nov; 577(Pt 1):5-15. PubMed ID: 16973695
[TBL] [Abstract][Full Text] [Related]
8. Cyclic adenosine 3',5'-monophosphate (cAMP)-dependent protein kinases, but not exchange proteins directly activated by cAMP (Epac), mediate thyrotropin/cAMP-dependent regulation of thyroid cells.
Dremier S; Milenkovic M; Blancquaert S; Dumont JE; Døskeland SO; Maenhaut C; Roger PP
Endocrinology; 2007 Oct; 148(10):4612-22. PubMed ID: 17584967
[TBL] [Abstract][Full Text] [Related]
9. Epac Signaling Is Required for Cocaine-Induced Change in AMPA Receptor Subunit Composition in the Ventral Tegmental Area.
Liu X; Chen Y; Tong J; Reynolds AM; Proudfoot SC; Qi J; Penzes P; Lu Y; Liu QS
J Neurosci; 2016 Apr; 36(17):4802-15. PubMed ID: 27122037
[TBL] [Abstract][Full Text] [Related]
10. cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells.
Kang G; Chepurny OG; Malester B; Rindler MJ; Rehmann H; Bos JL; Schwede F; Coetzee WA; Holz GG
J Physiol; 2006 Jun; 573(Pt 3):595-609. PubMed ID: 16613879
[TBL] [Abstract][Full Text] [Related]
11. Broad Impact of Exchange Protein Directly Activated by cAMP 2 (EPAC2) on Respiratory Viral Infections.
Choi EJ; Wu W; Cong X; Zhang K; Luo J; Ye S; Wang P; Suresh A; Ullah UM; Zhou J; Bao X
Viruses; 2021 Jun; 13(6):. PubMed ID: 34205489
[TBL] [Abstract][Full Text] [Related]
12. EPAC Negatively Regulates Myelination via Controlling Proliferation of Oligodendrocyte Precursor Cells.
Gao ZZ; Li YC; Shao CY; Xiao J; Shen Y; Zhou L
Neurosci Bull; 2020 Jun; 36(6):639-648. PubMed ID: 32303914
[TBL] [Abstract][Full Text] [Related]
13. Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology.
Métrich M; Berthouze M; Morel E; Crozatier B; Gomez AM; Lezoualc'h F
Pflugers Arch; 2010 Mar; 459(4):535-46. PubMed ID: 19855995
[TBL] [Abstract][Full Text] [Related]
14. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
[TBL] [Abstract][Full Text] [Related]
15. Repercussion of cAMP and EPAC in Memory and Signaling.
Naz S; Mahmood T; Ahsan F; Rizvi AA; Shamim A
Drug Res (Stuttg); 2022 Feb; 72(2):65-71. PubMed ID: 34979574
[TBL] [Abstract][Full Text] [Related]
16. Role of EPAC in cAMP-Mediated Actions in Adrenocortical Cells.
Lewis AE; Aesoy R; Bakke M
Front Endocrinol (Lausanne); 2016; 7():63. PubMed ID: 27379015
[TBL] [Abstract][Full Text] [Related]
17. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
[TBL] [Abstract][Full Text] [Related]
18. Epac: new emerging cAMP-binding protein.
Lee K
BMB Rep; 2021 Mar; 54(3):149-156. PubMed ID: 33298248
[TBL] [Abstract][Full Text] [Related]
19. EPAC1 and EPAC2 promote nociceptor hyperactivity associated with chronic pain after spinal cord injury.
Berkey SC; Herrera JJ; Odem MA; Rahman S; Cheruvu SS; Cheng X; Walters ET; Dessauer CW; Bavencoffe AG
Neurobiol Pain; 2020; 7():100040. PubMed ID: 31890991
[TBL] [Abstract][Full Text] [Related]
20. The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.
McKean JS; Murray F; Gibson G; Shewan DA; Tucker SJ; Nixon GF
Cardiovasc Res; 2015 Sep; 107(4):546-55. PubMed ID: 26092100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
